APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

IL-17 Monoclonal Antibody Injections

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global IL-17 Monoclonal Antibody Injections Market Analysis and Forecast 2026-2032

Report ID 174001610229 December 2025194 pages

Choose your research edition.

Industry ResearchIL-17 Monoclonal Antibody Injections Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-17 Monoclonal Antibody Injections Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal IL-17 Monoclonal Antibody Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-17 Monoclonal Antibody Injections Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-17 Monoclonal Antibody Injections Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global IL-17 Monoclonal Antibody Injections market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for IL-17 Monoclonal Antibody Injections is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for IL-17 Monoclonal Antibody Injections is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for IL-17 Monoclonal Antibody Injections is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for IL-17 Monoclonal Antibody Injections is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of IL-17 Monoclonal Antibody Injections include Novartis, Eli Lilly and Co., UCB and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for IL-17 Monoclonal Antibody Injections, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of IL-17 Monoclonal Antibody Injections, also provides the sales of main regions and countries. Of the upcoming market potential for IL-17 Monoclonal Antibody Injections, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the IL-17 Monoclonal Antibody Injections sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global IL-17 Monoclonal Antibody Injections market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for IL-17 Monoclonal Antibody Injections sales, projected growth trends, production technology, application and end-user industry.

IL-17 Monoclonal Antibody Injections Segment by Company

Novartis

Eli Lilly and Co.

UCB

AstraZeneca

IL-17 Monoclonal Antibody Injections Segment by Type

Human Origin

Rat Origin

Other

IL-17 Monoclonal Antibody Injections Segment by Application

Hospital

Clinic

Other

IL-17 Monoclonal Antibody Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-17 Monoclonal Antibody Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-17 Monoclonal Antibody Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-17 Monoclonal Antibody Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of IL-17 Monoclonal Antibody Injections in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of IL-17 Monoclonal Antibody Injections manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IL-17 Monoclonal Antibody Injections sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global IL-17 Monoclonal Antibody Injections Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Human Origin Major Manufacturers Table 3. Rat Origin Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global IL-17 Monoclonal Antibody Injections Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. IL-17 Monoclonal Antibody Injections Industry Trends Table 10. IL-17 Monoclonal Antibody Injections Industry Drivers Table 11. IL-17 Monoclonal Antibody Injections Industry Opportunities and Challenges Table 12. IL-17 Monoclonal Antibody Injections Industry Restraints Table 13. Global IL-17 Monoclonal Antibody Injections Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global IL-17 Monoclonal Antibody Injections Revenue by Region (2021-2026) & (US$ Million) Table 15. Global IL-17 Monoclonal Antibody Injections Revenue by Region (2027-2032) & (US$ Million) Table 16. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2021-2026) Table 17. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2027-2032) Table 18. Global IL-17 Monoclonal Antibody Injections Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global IL-17 Monoclonal Antibody Injections Sales by Region (2021-2026) & (K Units) Table 20. Global IL-17 Monoclonal Antibody Injections Sales by Region (2027-2032) & (K Units) Table 21. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2021-2026) Table 22. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2027-2032) Table 23. Global IL-17 Monoclonal Antibody Injections Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Manufacturers (2021-2026) Table 25. Global IL-17 Monoclonal Antibody Injections Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Manufacturers (2021-2026) Table 27. Global IL-17 Monoclonal Antibody Injections Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global IL-17 Monoclonal Antibody Injections Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global IL-17 Monoclonal Antibody Injections Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global IL-17 Monoclonal Antibody Injections Manufacturers, Product Type & Application Table 31. Global IL-17 Monoclonal Antibody Injections Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global IL-17 Monoclonal Antibody Injections by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global IL-17 Monoclonal Antibody Injections Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2026) & (US$ Million) Table 36. Global IL-17 Monoclonal Antibody Injections Revenue by Type (2027-2032) & (US$ Million) Table 37. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021-2026) Table 38. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2027-2032) Table 39. Global IL-17 Monoclonal Antibody Injections Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 41. Global IL-17 Monoclonal Antibody Injections Sales by Type (2027-2032) & (K Units) Table 42. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2026) Table 43. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2027-2032) Table 44. Global IL-17 Monoclonal Antibody Injections Price by Type (2021-2026) & (US$/Unit) Table 45. Global IL-17 Monoclonal Antibody Injections Price by Type (2027-2032) & (US$/Unit) Table 46. Global IL-17 Monoclonal Antibody Injections Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2026) & (US$ Million) Table 48. Global IL-17 Monoclonal Antibody Injections Revenue by Application (2027-2032) & (US$ Million) Table 49. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2021-2026) Table 50. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2027-2032) Table 51. Global IL-17 Monoclonal Antibody Injections Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 53. Global IL-17 Monoclonal Antibody Injections Sales by Application (2027-2032) & (K Units) Table 54. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2026) Table 55. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2027-2032) Table 56. Global IL-17 Monoclonal Antibody Injections Price by Application (2021-2026) & (US$/Unit) Table 57. Global IL-17 Monoclonal Antibody Injections Price by Application (2027-2032) & (US$/Unit) Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Novartis IL-17 Monoclonal Antibody Injections Product Portfolio Table 62. Novartis Recent Development Table 63. Eli Lilly and Co. Company Information Table 64. Eli Lilly and Co. Business Overview Table 65. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolio Table 67. Eli Lilly and Co. Recent Development Table 68. UCB Company Information Table 69. UCB Business Overview Table 70. UCB IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. UCB IL-17 Monoclonal Antibody Injections Product Portfolio Table 72. UCB Recent Development Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca IL-17 Monoclonal Antibody Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolio Table 77. AstraZeneca Recent Development Table 78. North America IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2026) & (US$ Million) Table 79. North America IL-17 Monoclonal Antibody Injections Revenue by Type (2027-2032) & (US$ Million) Table 80. North America IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 81. North America IL-17 Monoclonal Antibody Injections Sales by Type (2027-2032) & (K Units) Table 82. North America IL-17 Monoclonal Antibody Injections Sales Price by Type (2021-2026) & (US$/Unit) Table 83. North America IL-17 Monoclonal Antibody Injections Sales Price by Type (2027-2032) & (US$/Unit) Table 84. North America IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2026) & (US$ Million) Table 85. North America IL-17 Monoclonal Antibody Injections Revenue by Application (2027-2032) & (US$ Million) Table 86. North America IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 87. North America IL-17 Monoclonal Antibody Injections Sales by Application (2027-2032) & (K Units) Table 88. North America IL-17 Monoclonal Antibody Injections Sales Price by Application (2021-2026) & (US$/Unit) Table 89. North America IL-17 Monoclonal Antibody Injections Sales Price by Application (2027-2032) & (US$/Unit) Table 90. North America IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 92. North America IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 93. North America IL-17 Monoclonal Antibody Injections Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 94. North America IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 95. North America IL-17 Monoclonal Antibody Injections Sales by Country (2027-2032) & (K Units) Table 96. North America IL-17 Monoclonal Antibody Injections Sales Price by Country (2021-2026) & (US$/Unit) Table 97. North America IL-17 Monoclonal Antibody Injections Sales Price by Country (2027-2032) & (US$/Unit) Table 98. United States IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 99. Canada IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 100. Mexico IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 101. Europe IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe IL-17 Monoclonal Antibody Injections Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 104. Europe IL-17 Monoclonal Antibody Injections Sales by Type (2027-2032) & (K Units) Table 105. Europe IL-17 Monoclonal Antibody Injections Sales Price by Type (2021-2026) & (US$/Unit) Table 106. Europe IL-17 Monoclonal Antibody Injections Sales Price by Type (2027-2032) & (US$/Unit) Table 107. Europe IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe IL-17 Monoclonal Antibody Injections Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 110. Europe IL-17 Monoclonal Antibody Injections Sales by Application (2027-2032) & (K Units) Table 111. Europe IL-17 Monoclonal Antibody Injections Sales Price by Application (2021-2026) & (US$/Unit) Table 112. Europe IL-17 Monoclonal Antibody Injections Sales Price by Application (2027-2032) & (US$/Unit) Table 113. Europe IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. Europe IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 117. Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 118. Europe IL-17 Monoclonal Antibody Injections Sales by Country (2027-2032) & (K Units) Table 119. Europe IL-17 Monoclonal Antibody Injections Sales Price by Country (2021-2026) & (US$/Unit) Table 120. Europe IL-17 Monoclonal Antibody Injections Sales Price by Country (2027-2032) & (US$/Unit) Table 121. Germany IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 122. France IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 123. U.K. IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 124. Italy IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 125. Russia IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 126. Spain IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 127. Netherlands IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 128. Switzerland IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 129. Sweden IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 130. Poland IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 131. China IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2026) & (US$ Million) Table 132. China IL-17 Monoclonal Antibody Injections Revenue by Type (2027-2032) & (US$ Million) Table 133. China IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 134. China IL-17 Monoclonal Antibody Injections Sales by Type (2027-2032) & (K Units) Table 135. China IL-17 Monoclonal Antibody Injections Sales Price by Type (2021-2026) & (US$/Unit) Table 136. China IL-17 Monoclonal Antibody Injections Sales Price by Type (2027-2032) & (US$/Unit) Table 137. China IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2026) & (US$ Million) Table 138. China IL-17 Monoclonal Antibody Injections Revenue by Application (2027-2032) & (US$ Million) Table 139. China IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 140. China IL-17 Monoclonal Antibody Injections Sales by Application (2027-2032) & (K Units) Table 141. China IL-17 Monoclonal Antibody Injections Sales Price by Application (2021-2026) & (US$/Unit) Table 142. China IL-17 Monoclonal Antibody Injections Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia IL-17 Monoclonal Antibody Injections Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 146. Asia IL-17 Monoclonal Antibody Injections Sales by Type (2027-2032) & (K Units) Table 147. Asia IL-17 Monoclonal Antibody Injections Sales Price by Type (2021-2026) & (US$/Unit) Table 148. Asia IL-17 Monoclonal Antibody Injections Sales Price by Type (2027-2032) & (US$/Unit) Table 149. Asia IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2026) & (US$ Million) Table 150. Asia IL-17 Monoclonal Antibody Injections Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 152. Asia IL-17 Monoclonal Antibody Injections Sales by Application (2027-2032) & (K Units) Table 153. Asia IL-17 Monoclonal Antibody Injections Sales Price by Application (2021-2026) & (US$/Unit) Table 154. Asia IL-17 Monoclonal Antibody Injections Sales Price by Application (2027-2032) & (US$/Unit) Table 155. Asia IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. Asia IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. Asia IL-17 Monoclonal Antibody Injections Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 159. Asia IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 160. Asia IL-17 Monoclonal Antibody Injections Sales by Country (2027-2032) & (K Units) Table 161. Asia IL-17 Monoclonal Antibody Injections Sales Price by Country (2021-2026) & (US$/Unit) Table 162. Asia IL-17 Monoclonal Antibody Injections Sales Price by Country (2027-2032) & (US$/Unit) Table 163. Japan IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 164. South Korea IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 165. India IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 166. Australia IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 167. Taiwan IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 168. Southeast Asia IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 169. SAMEA IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2026) & (US$ Million) Table 170. SAMEA IL-17 Monoclonal Antibody Injections Revenue by Type (2027-2032) & (US$ Million) Table 171. SAMEA IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 172. SAMEA IL-17 Monoclonal Antibody Injections Sales by Type (2027-2032) & (K Units) Table 173. SAMEA IL-17 Monoclonal Antibody Injections Sales Price by Type (2021-2026) & (US$/Unit) Table 174. SAMEA IL-17 Monoclonal Antibody Injections Sales Price by Type (2027-2032) & (US$/Unit) Table 175. SAMEA IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2026) & (US$ Million) Table 176. SAMEA IL-17 Monoclonal Antibody Injections Revenue by Application (2027-2032) & (US$ Million) Table 177. SAMEA IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 178. SAMEA IL-17 Monoclonal Antibody Injections Sales by Application (2027-2032) & (K Units) Table 179. SAMEA IL-17 Monoclonal Antibody Injections Sales Price by Application (2021-2026) & (US$/Unit) Table 180. SAMEA IL-17 Monoclonal Antibody Injections Sales Price by Application (2027-2032) & (US$/Unit) Table 181. SAMEA IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. SAMEA IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. SAMEA IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. SAMEA IL-17 Monoclonal Antibody Injections Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 185. SAMEA IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 186. SAMEA IL-17 Monoclonal Antibody Injections Sales by Country (2027-2032) & (K Units) Table 187. SAMEA IL-17 Monoclonal Antibody Injections Sales Price by Country (2021-2026) & (US$/Unit) Table 188. SAMEA IL-17 Monoclonal Antibody Injections Sales Price by Country (2027-2032) & (US$/Unit) Table 189. Brazil IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 190. Argentina IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 191. Chile IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 192. Colombia IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 193. Peru IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 194. Saudi Arabia IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 195. Israel IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 196. UAE IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 197. Turkey IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 198. Iran IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 199. Egypt IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. IL-17 Monoclonal Antibody Injections Distributors List Table 203. IL-17 Monoclonal Antibody Injections Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. IL-17 Monoclonal Antibody Injections Image Figure 2. Global IL-17 Monoclonal Antibody Injections Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-17 Monoclonal Antibody Injections Market Size Share 2021 VS 2025 VS 2032 Figure 4. Human Origin Image Figure 5. Rat Origin Image Figure 6. Other Image Figure 7. Global IL-17 Monoclonal Antibody Injections Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global IL-17 Monoclonal Antibody Injections Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global IL-17 Monoclonal Antibody Injections Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Figure 14. Global IL-17 Monoclonal Antibody Injections Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2021-2032) Figure 17. Global IL-17 Monoclonal Antibody Injections Sales (2021-2032) & (K Units) Figure 18. Global IL-17 Monoclonal Antibody Injections Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico IL-17 Monoclonal Antibody Injections Sales YoY (2021-2032) & (K Units) Figure 21. Europe IL-17 Monoclonal Antibody Injections Sales YoY (2021-2032) & (K Units) Figure 22. China IL-17 Monoclonal Antibody Injections Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) IL-17 Monoclonal Antibody Injections Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Sales YoY (2021-2032) & (K Units) Figure 25. Global IL-17 Monoclonal Antibody Injections Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global IL-17 Monoclonal Antibody Injections Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021-2032) Figure 31. Global IL-17 Monoclonal Antibody Injections Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2032) Figure 34. Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2021-2032) Figure 37. Global IL-17 Monoclonal Antibody Injections Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2032) Figure 40. North America IL-17 Monoclonal Antibody Injections Revenue Share by Type (2021-2032) Figure 41. North America IL-17 Monoclonal Antibody Injections Sales Share by Type (2021-2032) Figure 42. North America IL-17 Monoclonal Antibody Injections Revenue Share by Application (2021-2032) Figure 43. North America IL-17 Monoclonal Antibody Injections Sales Share by Application (2021-2032) Figure 44. North America IL-17 Monoclonal Antibody Injections Revenue Share by Country (2021-2032) Figure 45. North America IL-17 Monoclonal Antibody Injections Sales Share by Country (2021-2032) Figure 46. Europe IL-17 Monoclonal Antibody Injections Revenue Share by Type (2021-2032) Figure 47. Europe IL-17 Monoclonal Antibody Injections Sales Share by Type (2021-2032) Figure 48. Europe IL-17 Monoclonal Antibody Injections Revenue Share by Application (2021-2032) Figure 49. Europe IL-17 Monoclonal Antibody Injections Sales Share by Application (2021-2032) Figure 50. Europe IL-17 Monoclonal Antibody Injections Revenue Share by Country (2021-2032) Figure 51. Europe IL-17 Monoclonal Antibody Injections Sales Share by Country (2021-2032) Figure 52. China IL-17 Monoclonal Antibody Injections Revenue Share by Type (2021-2032) Figure 53. China IL-17 Monoclonal Antibody Injections Sales Share by Type (2021-2032) Figure 54. China IL-17 Monoclonal Antibody Injections Revenue Share by Application (2021-2032) Figure 55. China IL-17 Monoclonal Antibody Injections Sales Share by Application (2021-2032) Figure 56. Asia IL-17 Monoclonal Antibody Injections Revenue Share by Type (2021-2032) Figure 57. Asia IL-17 Monoclonal Antibody Injections Sales Share by Type (2021-2032) Figure 58. Asia IL-17 Monoclonal Antibody Injections Revenue Share by Application (2021-2032) Figure 59. Asia IL-17 Monoclonal Antibody Injections Sales Share by Application (2021-2032) Figure 60. Asia IL-17 Monoclonal Antibody Injections Revenue Share by Country (2021-2032) Figure 61. Asia IL-17 Monoclonal Antibody Injections Sales Share by Country (2021-2032) Figure 62. SAMEA IL-17 Monoclonal Antibody Injections Revenue Share by Type (2021-2032) Figure 63. SAMEA IL-17 Monoclonal Antibody Injections Sales Share by Type (2021-2032) Figure 64. SAMEA IL-17 Monoclonal Antibody Injections Revenue Share by Application (2021-2032) Figure 65. SAMEA IL-17 Monoclonal Antibody Injections Sales Share by Application (2021-2032) Figure 66. SAMEA IL-17 Monoclonal Antibody Injections Revenue Share by Country (2021-2032) Figure 67. SAMEA IL-17 Monoclonal Antibody Injections Sales Share by Country (2021-2032) Figure 68. IL-17 Monoclonal Antibody Injections Value Chain Figure 69. Manufacturing Cost Structure Figure 70. IL-17 Monoclonal Antibody Injections Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Human Origin
  • Rat Origin
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novartis
  • Eli Lilly and Co.
  • UCB
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 IL-17 Monoclonal Antibody Injections Market by Type
  3. 1.2.1 Global IL-17 Monoclonal Antibody Injections Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Human Origin
  5. 1.2.3 Rat Origin
  6. 1.2.4 Other
  7. 1.3 IL-17 Monoclonal Antibody Injections Market by Application
  8. 1.3.1 Global IL-17 Monoclonal Antibody Injections Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 IL-17 Monoclonal Antibody Injections Market Dynamics
  1. 2.1 IL-17 Monoclonal Antibody Injections Industry Trends
  2. 2.2 IL-17 Monoclonal Antibody Injections Industry Drivers
  3. 2.3 IL-17 Monoclonal Antibody Injections Industry Opportunities and Challenges
  4. 2.4 IL-17 Monoclonal Antibody Injections Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global IL-17 Monoclonal Antibody Injections Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global IL-17 Monoclonal Antibody Injections Revenue by Region
  3. 3.2.1 Global IL-17 Monoclonal Antibody Injections Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global IL-17 Monoclonal Antibody Injections Revenue by Region (2021-2026)
  5. 3.2.3 Global IL-17 Monoclonal Antibody Injections Revenue by Region (2027-2032)
  6. 3.2.4 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2021-2032)
  7. 3.3 Global IL-17 Monoclonal Antibody Injections Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global IL-17 Monoclonal Antibody Injections Sales by Region
  9. 3.4.1 Global IL-17 Monoclonal Antibody Injections Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global IL-17 Monoclonal Antibody Injections Sales by Region (2021-2026)
  11. 3.4.3 Global IL-17 Monoclonal Antibody Injections Sales by Region (2027-2032)
  12. 3.4.4 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global IL-17 Monoclonal Antibody Injections Revenue by Manufacturers
  2. 4.1.1 Global IL-17 Monoclonal Antibody Injections Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global IL-17 Monoclonal Antibody Injections Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global IL-17 Monoclonal Antibody Injections Sales by Manufacturers
  6. 4.2.1 Global IL-17 Monoclonal Antibody Injections Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global IL-17 Monoclonal Antibody Injections Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global IL-17 Monoclonal Antibody Injections Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global IL-17 Monoclonal Antibody Injections Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global IL-17 Monoclonal Antibody Injections Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global IL-17 Monoclonal Antibody Injections Manufacturers, Product Type & Application
  13. 4.7 Global IL-17 Monoclonal Antibody Injections Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global IL-17 Monoclonal Antibody Injections Market CR5 and HHI
  16. 4.8.2 2025 IL-17 Monoclonal Antibody Injections Tier 1, Tier 2, and Tier 3
5 IL-17 Monoclonal Antibody Injections Market by Type
  1. 5.1 Global IL-17 Monoclonal Antibody Injections Revenue by Type
  2. 5.1.1 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021-2032)
  5. 5.2 Global IL-17 Monoclonal Antibody Injections Sales by Type
  6. 5.2.1 Global IL-17 Monoclonal Antibody Injections Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global IL-17 Monoclonal Antibody Injections Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2032)
  9. 5.3 Global IL-17 Monoclonal Antibody Injections Price by Type
6 IL-17 Monoclonal Antibody Injections Market by Application
  1. 6.1 Global IL-17 Monoclonal Antibody Injections Revenue by Application
  2. 6.1.1 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2021-2032)
  5. 6.2 Global IL-17 Monoclonal Antibody Injections Sales by Application
  6. 6.2.1 Global IL-17 Monoclonal Antibody Injections Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global IL-17 Monoclonal Antibody Injections Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2032)
  9. 6.3 Global IL-17 Monoclonal Antibody Injections Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis IL-17 Monoclonal Antibody Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis IL-17 Monoclonal Antibody Injections Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Eli Lilly and Co.
  8. 7.2.1 Eli Lilly and Co. Company Information
  9. 7.2.2 Eli Lilly and Co. Business Overview
  10. 7.2.3 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolio
  12. 7.2.5 Eli Lilly and Co. Recent Developments
  13. 7.3 UCB
  14. 7.3.1 UCB Company Information
  15. 7.3.2 UCB Business Overview
  16. 7.3.3 UCB IL-17 Monoclonal Antibody Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 UCB IL-17 Monoclonal Antibody Injections Product Portfolio
  18. 7.3.5 UCB Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca IL-17 Monoclonal Antibody Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
8 North America
  1. 8.1 North America IL-17 Monoclonal Antibody Injections Market Size by Type
  2. 8.1.1 North America IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2032)
  3. 8.1.2 North America IL-17 Monoclonal Antibody Injections Sales by Type (2021-2032)
  4. 8.1.3 North America IL-17 Monoclonal Antibody Injections Price by Type (2021-2032)
  5. 8.2 North America IL-17 Monoclonal Antibody Injections Market Size by Application
  6. 8.2.1 North America IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2032)
  7. 8.2.2 North America IL-17 Monoclonal Antibody Injections Sales by Application (2021-2032)
  8. 8.2.3 North America IL-17 Monoclonal Antibody Injections Price by Application (2021-2032)
  9. 8.3 North America IL-17 Monoclonal Antibody Injections Market Size by Country
  10. 8.3.1 North America IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America IL-17 Monoclonal Antibody Injections Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America IL-17 Monoclonal Antibody Injections Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe IL-17 Monoclonal Antibody Injections Market Size by Type
  2. 9.1.1 Europe IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2032)
  3. 9.1.2 Europe IL-17 Monoclonal Antibody Injections Sales by Type (2021-2032)
  4. 9.1.3 Europe IL-17 Monoclonal Antibody Injections Price by Type (2021-2032)
  5. 9.2 Europe IL-17 Monoclonal Antibody Injections Market Size by Application
  6. 9.2.1 Europe IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2032)
  7. 9.2.2 Europe IL-17 Monoclonal Antibody Injections Sales by Application (2021-2032)
  8. 9.2.3 Europe IL-17 Monoclonal Antibody Injections Price by Application (2021-2032)
  9. 9.3 Europe IL-17 Monoclonal Antibody Injections Market Size by Country
  10. 9.3.1 Europe IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe IL-17 Monoclonal Antibody Injections Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China IL-17 Monoclonal Antibody Injections Market Size by Type
  2. 10.1.1 China IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2032)
  3. 10.1.2 China IL-17 Monoclonal Antibody Injections Sales by Type (2021-2032)
  4. 10.1.3 China IL-17 Monoclonal Antibody Injections Price by Type (2021-2032)
  5. 10.2 China IL-17 Monoclonal Antibody Injections Market Size by Application
  6. 10.2.1 China IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2032)
  7. 10.2.2 China IL-17 Monoclonal Antibody Injections Sales by Application (2021-2032)
  8. 10.2.3 China IL-17 Monoclonal Antibody Injections Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia IL-17 Monoclonal Antibody Injections Market Size by Type
  2. 11.1.1 Asia IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2032)
  3. 11.1.2 Asia IL-17 Monoclonal Antibody Injections Sales by Type (2021-2032)
  4. 11.1.3 Asia IL-17 Monoclonal Antibody Injections Price by Type (2021-2032)
  5. 11.2 Asia IL-17 Monoclonal Antibody Injections Market Size by Application
  6. 11.2.1 Asia IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2032)
  7. 11.2.2 Asia IL-17 Monoclonal Antibody Injections Sales by Application (2021-2032)
  8. 11.2.3 Asia IL-17 Monoclonal Antibody Injections Price by Application (2021-2032)
  9. 11.3 Asia IL-17 Monoclonal Antibody Injections Market Size by Country
  10. 11.3.1 Asia IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia IL-17 Monoclonal Antibody Injections Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia IL-17 Monoclonal Antibody Injections Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA IL-17 Monoclonal Antibody Injections Market Size by Type
  2. 12.1.1 SAMEA IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA IL-17 Monoclonal Antibody Injections Sales by Type (2021-2032)
  4. 12.1.3 SAMEA IL-17 Monoclonal Antibody Injections Price by Type (2021-2032)
  5. 12.2 SAMEA IL-17 Monoclonal Antibody Injections Market Size by Application
  6. 12.2.1 SAMEA IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA IL-17 Monoclonal Antibody Injections Sales by Application (2021-2032)
  8. 12.2.3 SAMEA IL-17 Monoclonal Antibody Injections Price by Application (2021-2032)
  9. 12.3 SAMEA IL-17 Monoclonal Antibody Injections Market Size by Country
  10. 12.3.1 SAMEA IL-17 Monoclonal Antibody Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA IL-17 Monoclonal Antibody Injections Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA IL-17 Monoclonal Antibody Injections Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 IL-17 Monoclonal Antibody Injections Value Chain Analysis
  2. 13.1.1 IL-17 Monoclonal Antibody Injections Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 IL-17 Monoclonal Antibody Injections Production Mode & Process
  6. 13.2 IL-17 Monoclonal Antibody Injections Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 IL-17 Monoclonal Antibody Injections Distributors
  9. 13.2.3 IL-17 Monoclonal Antibody Injections Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst